Risk of COVID-19 for patients with cancer

Affiliations

¹ Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
² Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
³ Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China. Electronic address: huahaoshen@zju.edu.cn.

Comment

Yang Xia et al. Lancet Oncol. 2020 Apr.

. 2020 Apr;21(4):e180.

doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.

¹ Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
² Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
³ Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China. Electronic address: huahaoshen@zju.edu.cn.

No abstract available

Comment in

Challenges posed by COVID-19 to children with cancer.
Kotecha RS. Kotecha RS. Lancet Oncol. 2020 May;21(5):e235. doi: 10.1016/S1470-2045(20)30205-9. Epub 2020 Mar 25. Lancet Oncol. 2020. PMID: 32220660 Free PMC article. No abstract available.
COVID-19 outbreak and cancer patient management: Viewpoint from radio-oncologists.
Zhen H, Zhang F, Guan H, Liu Z, Shen J, Hou X, Lian X, Hu K. Zhen H, et al. Radiother Oncol. 2020 Aug;149:44-45. doi: 10.1016/j.radonc.2020.04.025. Epub 2020 May 8. Radiother Oncol. 2020. PMID: 32389756 Free PMC article. No abstract available.

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Liang W, et al. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14. Lancet Oncol. 2020. PMID: 32066541 Free PMC article. No abstract available.

1. Liang W, Guan W, Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 doi: 10.1016/S1470-2045(20)30096-6. published online Feb 14. - DOI - PMC - PubMed
1. Xu Z, Shi L, Wang Y, Zhang J. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30076-X. published online Feb 18. - DOI - PMC - PubMed
1. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011;331:1565–1570. - PubMed
1. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020 doi: 10.1101/2020.02.05.20020107. (preprint). - DOI
1. Guan W-J, Ni Z-Y, Hu Y. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020 doi: 10.1101/2020.02.06.20020974. (preprint). - DOI